Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 5,251–5,275 of 27,380 studies, newest first · page 211 of 1096.

February 2025 25

  1. 2025-02-12

    Salmonellosis in Cattle: Sources and Risk of Infection, Control, and Prevention

    ✓ Peer-reviewed Prevention and risk Zoonotic Diseases

    Key finding: We conclude that a holistic approach involving all stakeholders in cattle production is needed to safeguard public health, eventually forestalling human salmonellosis from cattle sources.

  2. 2025-02-12

    Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease

    ✓ Peer-reviewed Prevention and risk Annals of Medicine

    Key finding: Reasonable nutrient intake encompassing macronutrients and micronutrients have an independent protective relationship with NAFLD. +4 more findings

  3. 2025-02-12

    Analytical Review on Nutritional Deficiencies in Vegan Diets: Risks, Prevention, and Optimal Strategies

    ✓ Peer-reviewed Prevention and risk Journal of the American Nutrition Association

    Key finding: While studies confirm that veganism reduces the risk of chronic diseases, such as diabetes, obesity, and heart disease, significant challenges persist in meeting nutritional needs. +3 more findings

  4. 2025-02-12

    Colorectal Cancer: Epidemiology, Risk Factors, and Public Health Strategies

    ✓ Peer-reviewed Prevention and risk Digestion

    Key finding: Enhancing CRC screening, early detection, and public health interventions can significantly reduce CRC-related mortality. +2 more findings

  5. 2025-02-11

    L-Lactate Administration Improved Synaptic Plasticity and Cognition in Early 3xTg-AD Mice

    ✓ Peer-reviewed Disease mechanisms International journal of molecular sciences

    Key finding: Our findings reveal significant reductions in hippocampal lactate levels in experimental AD mice. +3 more findings

  6. 2025-02-11

    Development of Neurodegenerative Disease Diagnosis and Monitoring from Traditional to Digital Biomarkers

    ✓ Peer-reviewed Cognitive tests and assessment Biosensors

    Key finding: Monitoring and assessing the progression of symptoms in neurodegenerative diseases, including Alzheimer's and Parkinson's disease, are critical for improving patient outcomes. +4 more findings

  7. 2025-02-11

    White matter hyperintensity severity modifies gut metabolite association with cognitive outcomes

    ✓ Peer-reviewed Vascular contributions The Journal of Prevention of Alzheimer s Disease

    Key finding: Of 104 metabolites studied, glycodeoxycholic acid (GDCA) surpassed the false discovery rate and was associated the Alzheimer's Disease Assessment Scale-Cognitive Subscale version 13 (ADAS-Cog13) score (β = 0.12, 95 % CI = 0.05-0.20, p = 0.001) and cognitive impairment determined by mini-mental status exam (MMSE) (OR = 2.11, 95 % CI = 1.41-3.15, p < 0.001). +3 more findings

  8. 2025-02-11

    Proteolytic therapeutic modalities for amyloidoses: Insights into immunotherapy, PROTAC, and photo-oxygenation

    ✓ Peer-reviewed Disease mechanisms Neurotherapeutics

    Key finding: PROTAC is a small molecule that uses the ubiquitin-proteasome system to degrade intracellular target proteins and has demonstrated efficacy in clinical trials for other diseases. +1 more finding

  9. 2025-02-11

    The Prevention of Fatal Tauopathy in a Mouse Model of Alzheimer Disease by Blocking BCL2

    ✓ Peer-reviewed Inflammation and the immune system Applied immunohistochemistry & molecular morphology

    Key finding: The treated mice were robust until sacrificed at 13 months as compared with the untreated mice that showed unequivocal evidence of brain and spinal cord damage both clinically and at autopsy. +1 more finding

  10. 2025-02-11

    Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease

    ✓ Peer-reviewed Inflammation and the immune system Journal of Neuroimmune Pharmacology

    Key finding: It primarily affects cerebral regions responsible for cognition, memory, and language processing, significantly impeding the functional independence of patients.

  11. 2025-02-11

    Comorbidity Trajectories Before and After the Diagnosis of Heart Failure: A UK Biobank Cohort Study

    ✓ Peer-reviewed Long-term cohort studies European Journal of Heart Failure

    Key finding: We identified all participants in the UK Biobank cohort study diagnosed with HF prior to enrolment or during follow-up, who had disease occurrence data available from both primary and secondary care records (n = 9824). +4 more findings

  12. 2025-02-11

    The Cortical Asymmetry Index for subtyping dementia patients

    ✓ Peer-reviewed Cognitive tests and assessment European Radiology

    Key finding: A total of 101 FTD patients (64 ± 8 years, 53 men), 230 AD patients (65 ± 10 years, 84 men), and 173 CTR (59 ± 15 years, 67 men) were studied. +4 more findings

  13. 2025-02-11

    Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production

    ✓ Peer-reviewed Risk genes beyond APOE eLife

    Key finding: We recently reported evidence that FAD mutations in APP and PSEN1 cause deficiencies in early steps in processive proteolysis of APP substrate C99 and that this results from stalled γ-secretase enzyme-substrate and/or enzyme-intermediate complexes. +2 more findings

  14. 2025-02-11

    From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease

    ✓ Peer-reviewed Risk factors Molecular Neurodegeneration

    Key finding: RBD pathophysiology is not fully clarified yet, but clinical and basic science suggest that ɑ-syn pathology begins in the lower brainstem where REM atonia circuits are located, including the sublaterodorsal tegmental/subcoeruleus nucleus and the ventral medulla, then propagates rostrally to brain regions such as the substantia nigra, limbic system, cortex.

  15. 2025-02-11

    Sundowning Syndrome in Dementia: Mechanisms, Diagnosis, and Treatment

    ✓ Peer-reviewed Caregiving Journal of Clinical Medicine

    Key finding: Therefore, patients with SS need very precise diagnostic workup aiming at defining the exact cause of the syndrome. +4 more findings

  16. 2025-02-11
  17. 2025-02-11

    Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset

    ✓ Peer-reviewed Getting a diagnosis Cortex

    Key finding: Moreover, we supported our result using a correlation-based approach on clinical and metabolic variables. 101 bvFTD (62 prodromal bvFTD) were enrolled (EO-bvFTD: n = 36, prodromal n = 21; LO-bvFTD: n = 36, prodromal: n = 22; vLO-bvFTD: n = 29, prodromal: n = 19). +3 more findings

  18. 2025-02-11
  19. 2025-02-10

    Circulating metabolomic profile of the MIND diet and its relation to cognition in middle‐aged and older adults

    ✓ Peer-reviewed Prevention trials iMetaOmics.

    Key finding: The Mediterranean-DASH Diet Intervention for Neurodegenerative Delay (MIND) diet has been related to a lower risk of dementia and better cognitive function. +3 more findings

  20. 2025-02-10

    AI-powered model for accurate prediction of MCI-to-AD progression

    ✓ Peer-reviewed Mild cognitive impairment Acta Pharmaceutica Sinica B

    Key finding: The performance of the BiGRU model was rigorously compared with several machine-learning model baselines to evaluate its efficacy. +1 more finding

  21. 2025-02-10
  22. 2025-02-10

    Use of Digital Health Technologies for Dementia Care: Bibliometric Analysis and Report

    ✓ Peer-reviewed Caregiving JMIR Mental Health

    Key finding: A total of 704 records met the inclusion criteria for bibliometric analysis. +4 more findings

  23. 2025-02-10
  24. 2025-02-10

    Joint control of multiple food processing contaminants in Maillard reaction: A comprehensive review of health risks and prevention

    ✓ Peer-reviewed Prevention and risk Comprehensive Reviews in Food Science and Food Safety

    Key finding: There is an urgent need to address food safety concerns associated with multiple Maillard reaction‒derived chemical contaminants, such as acrylamide, heterocyclic aromatic amines, advanced glycation end products, and 5-hydroxymethylfurfural, which are present in processed foods. +2 more findings

  25. 2025-02-10

    Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers

    ✓ Peer-reviewed Biomarkers JAMA neurology

    Key finding: AD was common in both AD-related syndromes (110/125 [88%]) and FTLD-related syndromes (45/198 [23%]). +1 more finding

Browse the library by subject, with the full score breakdown →